HSBC is to launch a groundbreaking ethical investment product for British savers to support vaccination programmes in the developing world.

The bank hopes to raise £50m through its "vaccines" Individual Savings Account targeted at retail investors, who will buy government-backed bonds to fund projects operated by the Global Alliance on Vaccines and Immunisation (GAVI), the Geneva-based multilateral.